About the Product

Description


Miratyle 25 Tablet contains Mirabegron (25mg), a beta-3 adrenergic receptor agonist used in the treatment of overactive bladder (OAB). It works by relaxing the detrusor muscle in the bladder, thereby improving bladder capacity and reducing the urgency, frequency, and episodes of urinary incontinence associated with OAB.

Mirabegron offers a unique mechanism of action compared to traditional anticholinergics, making it an effective and well-tolerated option for managing urinary symptoms. This medication is especially beneficial for patients who experience side effects from anticholinergic drugs or have contraindications to their use.

Common side effects may include: Increased blood pressure Headache Nasopharyngitis (cold symptoms) Dizziness Constipation Rarely, it may cause urinary retention or allergic reactions such as rash or swelling. Seek medical attention if severe side effects occur.

Management of overactive bladder (OAB) symptoms, including urgency, frequency, and urinary incontinence.

Take only as directed by a healthcare professional. Not recommended for patients with severe uncontrolled hypertension. Regular blood pressure monitoring is advised during treatment. Use cautiously in patients with liver or kidney impairment.

Store at a temperature below 25°C in a dry and cool environment. Keep the tablets in their original packaging, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions